<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394752/" ref="ordinalpos=2097&amp;ncbi_uid=1403182&amp;link_uid=PMC2394752" image-link="/pmc/articles/PMC2394752/figure/F1/" class="imagepopup">Figure 1.  From: A functional map of NF?B <span class="highlight" style="background-color:">signaling</span> identifies novel modulators and multiple system controls. </a></div><br /><div class="p4l_captionBody">Flowchart outlining the steps in the gain-of-function and loss-of-function genomic screens. The gain-of-function screen was used to identify positive modifiers of the NFÎºB signaling pathway and the loss-of-function screen was used to identify negative modifiers. Approximately 14,500 full-length human and mouse genes were screened for activity.</div></div>